HighTower Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-24,283
| Closed | -$2.26M | – | 3781 |
|
|
2021
Q4 | $2.26M | Buy |
24,283
+2,432
| +11% | +$160K | ﹤0.01% | 1299 |
|
|
2021
Q3 | $1.3M | Buy |
21,851
+12
| +0.1% | +$709 | ﹤0.01% | 1516 |
|
|
2021
Q2 | $1.49M | Sell |
21,839
-535
| -2% | -$34.9K | ﹤0.01% | 1411 |
|
|
2021
Q1 | $1.55M | Sell |
22,374
-180
| -0.8% | -$13.9K | ﹤0.01% | 1283 |
|
|
2020
Q4 | $1.73M | Sell |
22,554
-24,615
| -52% | -$1.84M | 0.01% | 974 |
|
|
2020
Q3 | $3.52M | Buy |
47,169
+22,810
| +94% | +$1.52M | 0.02% | 676 |
|
|
2020
Q2 | $1.53M | Buy |
24,359
+5,161
| +27% | +$284K | 0.01% | 913 |
|
|
2020
Q1 | $806K | Buy |
+19,198
| New | +$880K | 0.01% | 1112 |
|
|
2019
Q4 | – | Sell |
-18,048
| Closed | -$825K | – | 2593 |
|
|
2019
Q3 | $825K | Buy |
18,048
+3,693
| +26% | +$208K | ﹤0.01% | 1270 |
|
|
2019
Q2 | $842K | Buy |
14,355
+2,950
| +26% | +$152K | 0.01% | 1269 |
|
|
2019
Q1 | $511K | Sell |
11,405
-50
| -0.4% | -$2.29K | ﹤0.01% | 1449 |
|
|
2018
Q4 | $446K | Hold |
11,455
| – | – | ﹤0.01% | 1417 |
|
|
2018
Q3 | $527K | Sell |
11,455
-3,983
| -26% | -$161K | ﹤0.01% | 1435 |
|
|
2018
Q2 | $668K | Buy |
15,438
+7,914
| +105% | +$340K | 0.01% | 1315 |
|
|
2018
Q1 | $292K | Sell |
7,524
-6,102
| -45% | -$237K | ﹤0.01% | 1683 |
|
|
2017
Q4 | $461K | Buy |
13,626
+5,802
| +74% | +$165K | ﹤0.01% | 1478 |
|
|
2017
Q3 | $201K | Sell |
7,824
-2,846
| -27% | -$65.3K | ﹤0.01% | 1910 |
|
|
2017
Q2 | $177K | Buy |
10,670
+8,647
| +427% | +$119K | ﹤0.01% | 1860 |
|
|
2017
Q1 | $29K | Sell |
2,023
-50
| -2% | -$741 | ﹤0.01% | 1953 |
|
|
2016
Q4 | $30K | Buy |
2,073
+100
| +5% | +$1.55K | ﹤0.01% | 1842 |
|
|
2016
Q3 | $35K | Hold |
1,973
| – | – | ﹤0.01% | 1798 |
|
|
2016
Q2 | $34K | Buy |
+1,973
| New | +$35.3K | ﹤0.01% | 1660 |
|
HighTower Advisors's ARNA Position: Q1 2022 in Review
HighTower Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 24,283 shares — an estimated $2.26M sold.
HighTower Advisors first reported a position in ARNA in Q2 2016 and held it in 22 quarters. The position peaked at $3.52M in Q3 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- HighTower Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- HighTower Advisors sold 24,283 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.26M.
- HighTower Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2016 and held it in 22 quarters.
- HighTower Advisors's Arena Pharmaceuticals Inc position peaked at $3.52M in Q3 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on HighTower Advisors's 13F filing for Q1 2022, filed 12 May 2022.